1. Home
  2. Journals

American Journal of Cancer Research and Reviews

American Journal of Cancer Research and Reviews, Recent Articles

CARCINOMA OF THE UPPER LIP- CASE REPORT AND REVIEW OF THE LITERATURE

Case Report of American Journal of Cancer Research and Reviews CARCINOMA OF THE UPPER LIP- CASE REPORT AND REVIEW OF THE LITERATURE Luigi Clauser, MD,MFS1, Riccardo Luoni Orsi, DMD1, Andrea Edoardo Bianchi, MD,MFS1,2 1Unit of Maxillo-Facial Surgery, Istituto Stomatologico Italiano, Via Pace, 21, 20122 MILANO, Italy; 2Università UniCamillus-Saint Camillus International University,Via di Sant’Alessandro,8-00131 ROME, Italy Aim: Carcinoma of the upper lip is less frequent than in the lower lip. It affects both sexes in equal proportion. Histologically basal cell carcinomas are numerically preponderant and are observed in 50% of cases in the skin and adnexae in the oro-facial area. Methods: The authors describe a major defect of the right upper lip after a wide resection for carcinoma. Immediate reconstruction was performed  with rotation of a flap from the lower lip  according to Estlander. The postoperative oral deformity persisted after radiotherapy and during  the  subsequent follow up. At a later stage, and after radiotherapy, two lipostructure procedures improved the volumetric, soft tissue texture and functional outcomes. The combination of these techniques yielded a satisfactory morpho-functional result maintaining symmetry, function and aesthetics in the orofacial  and in the labial-commissure area. Conclusion: A clinical case of right upper lip basocellular carcinoma is reported. Resection and immediate reconstruction with a flap rotation from the lower  lip flap according to Estlander, were carried out. During the follow-up lipostructure procedures improved volumes, functions, morphology and soft tissue texture as well. Keywords: upper lip carcinoma, TNM, lip resection, combined rotation and advancement flaps, upper lip reconstruction, radiotherapy, lipostructure, regenerative medicine ...
American Journal of Cancer Research and Reviews, Recent Articles

MANDIBULAR OSTEONECROSIS RELATED TO THE USE OF BISPHOSPHONATE IN ONCOLOGY: CASE REPORT

Case Report of American Journal of Cancer Research and Reviews MANDIBULAR OSTEONECROSIS RELATED TO THE USE OF BISPHOSPHONATE IN ONCOLOGY: CASE REPORT Anna Danielly Almeida do Nascimento¹ *, Beatriz Santos Borges¹, Cristianne de Barros Santos¹, Laís Azevedo Lins de Holanda¹, Aurora Karla de Lacerda Vidal¹.  ¹ Instituto de Ciências Biológicas e Centro de Oncologia do Hospital Universitário Oswaldo Cruz da Universidade de Pernambuco (ICB/CEON/HUOC/UPE) Objective: Evidence that the inflammation, infection, necrosis and pain present in osteonecrosis may be related to the use of bisphosphonates in oncology. Methods: It’s a clinical case report of mandibular osteonecrosis, female, 73 years old, treated and under medical and multiprofessional oncology follow-up, at the Oncology Center of the Oswaldo Cruz University Hospital of the University of Pernambuco, for control of invasive ductal carcinoma of breast (Anatomopathological115134) and bilateral bone and lung metastases. Currently, using Faslodex 250mg - 02 ampoules and Zometa (bisphosphonate). Results: With a extraction history performed during the use of bisphosphonate, and with a removable upper and lower total dental prosthesis, attended the Dental Service of aforementioned Oncology Center, presenting bone exposure in the anterior mandible region and complaining of local pain. After clinical and radiographic evaluation, the diagnosis of osteonecrosis was confirmed, characterized by necrosis, pain and bone infection. Considering the mandibular clinical and radiographic condition, and the oncological condition, the Oral Care’s Standard Operational Protocol for Osteonecrosis was initiated, adapted from the Dentistry Service of the National Cancer Institute, but without the Low Power Laser. After 4 months, clinical improvement was noted and the absence of painful symptoms was reported. In addition, it follows the Oral Care Protocol and is being followed up at the aforementioned specialized Service. Conclusion: Invasive surgical procedures and local trauma should be avoided during therapy with bisphosphonates, as they can favor the development of osteonecrosis, in ...
American Journal of Cancer Research and Reviews, Recent Articles

Giant Cell Tumor of Bone, current treatments, and potential therapeutic alternatives

Review Article of American Journal of Cancer Research and Reviews Giant Cell Tumor of Bone, current treatments, and potential therapeutic alternatives Estrada-Villaseñor E.,1 Meneses A.,2 Valdés-Flores M.,3 Coutiño-Alcaraz JM.,4 Linares-González LM.,5 Olivos Meza A.,6 Ostoa-Saloma P.,7 Delgado Cedillo EA.,8 Landa Solís C.9 1National Institute of Rehabilitation. Pathology Service. Mexico City, México. 2National Cancer Institute. Managing Director. Mexico City, Mexico. 3National Institute of Rehabilitation. Assistant Manager Clinical Research in genetic service. Mexico City, México. 4National Institute of Rehabilitation. Pathology Service. Mexico City, Mexico. 5National Institute of Rehabilitation. Bone Tumors Service. Mexico City, Mexico. 6National Institute of Rehabilitation. Arthroscopy Service. Mexico City, México. 7Postgraduate degree in Biological Sciences, National Autonomous University of Mexico, University City, Mexico, Mexico City. 8National Institute of Rehabilitation. Bone Tumors Service. Mexico City, Mexico. 9National Institute of Rehabilitation. Tissue Engineering and Cell Therapy Unit. Mexico City, Mexico. Giant cell tumor of bone (GCTB) is a primary bone tumor, locally aggressive. For many, a GCTB is considered a tumor with an unpredictable behavior, particularly regarding recurrences, pulmonary implants, and the possibility of primary malignancy. In terms of risk of recurrence, it is known that it is associated with the type of treatment used initially for the GCTB. The greater the number or recurrences, the greater the risk of pulmonary implants, and the greater the risk of malignant degeneration. Therefore, much of the prognosis of this tumor could be related to the type of initial treatment. Hence the importance of the treatment theme. This review includes a comparison between the various modalities for treatment in GCTB, considering the advantages and disadvantages of each one. Existing GCTB treatments are not 100% safe and effective at the same time. and this is the reason why the search for other treatment modalities should continue to offer a better oncologic and functional outcome to ...
American Journal of Cancer Research and Reviews, Recent Articles

Application of Artificial Intelligence in Breast Medical Imaging Diagnosis

Review Article of American Journal of Cancer Research and Reviews Application of Artificial Intelligence in Breast Medical Imaging Diagnosis Yao Xiao1*, Yiyuan Qu1, Tingting Wu1 1College of Medicine, China Three Gorges University, Yichang, 443002, China. According to the latest report on urban cancer in China published in 2017: China is one of the countries with the fastest growing incidence of breast cancer, and the age of onset has gradually become younger. Newly diagnosed breast cancer patients in China account for 12.2% of new breast cancer patients worldwide, and the mortality rate is 9.6%. A large amount of clinical experience has proven that the survival rate of breast cancer detected at an early stage is significantly higher than that detected at an advanced stage. Imaging examination is an important method for early detection of breast cancer. With the advent of the Artificial Intelligent, the method of AI + medical imaging has been widely used in lungs, breasts, heart, skull, liver, prostate, bones and other parts. Methods used in breast cancer screening include: breast self-examination and clinical physical examination, mammography of mammography of the breast, ultrasound of the breast, and magnetic resonance imaging (MRI) of the breast. The advantages and disadvantages have been reflected in the development and application in recent years. This article will review the advantages and disadvantages of combined diagnosis of AI and breast medicine. It is hoped that the artificial intelligence of medical imaging screening for breast diseases has a brighter and broader prospect. Keywords: Breast; Medical imaging; Artificial intelligence (AI); Advantages and disadvantages ...

Manuscript Title: The title should be a brief phrase.

Author Information: List full names and affiliation of all authors, including Emails and phone numbers of corresponding author.

Abstract: The abstract should be less than 500 words. Following abstract, a list of keywords and abbreviations should be added. The keywords should be no more than 10. Abbreviation are only used for non standard and long terms.

Introduction: The introduction should included a clear statement of current problems.

Materials and Methods: This section should be clearly described.

Results and discussion: Authors may put results and discussion into a single section or show them separately.

Acknowledgement: This section includes a brief acknowledgment of people, grant details, funds

References: References should be listed in a numbered citation order at the end of articles. DOIs and links to referenced articles should be added if available. Abstracts and talks for conferences or papers not yet accepted should not be cited.

Tables and figures: Tables should be used at a minimum with a short descriptive title. The preferred file formats for Figures/Graphics are GIF, TIFF, JPEG or PowerPoint.

Online Publication: One of our goals is to minimize the publication time. We will publish an accepted article shortly (we may put the proof of accepted manuscript onlinefirst and then replace it later with the final version).

Open Access: We follow Open Access and the CC BY 4.0. Authors hold the copyright and retain publishing rights without restrictions. We do not charge any submission fees, but authors are required to pay publication fees after their manuscripts are accepted. We may grant discount/waiver to certain authors. For authors who receive our invitations, please send us the invitation code with your submission. 

Withdrawal Policy: When you want to withdraw/retract an article, please send us a written request including reasons by the correspondence email. We will withdraw/retract it from our system after reviewing the request.

Terms of Use/ Privacy Policy/ Disclaimer/Other Policies: By using the site/services, you are agreeing to our Terms of Use/Privacy Policy/Disclaimer/Other Policies. For more details, please click here .

About the journal
Our aim is to provide a platform that encourages publications of the most recent research/reviews for authors of all countries.

About the publisher
eSciPub LLC is a publisher to support Open Access initiative located in Texas, USA. It is a member of the largest community of professional publishers in the United States: the Independent Book Publishers Association. It hosts Open Access journals in Medicine, Business, Economics, Agriculture, Biological Sciences, Chemistry, Education, Physical Sciences, Sociology, Engineering.

Rapid Response Team
Please feel free to contact us if you have any questions. Our customer representative will answer your questions shortly.

American Journal of Cancer Research and Reviews

Loading